Clinical Trial Update: MARGetuximab Or Trastuzumab (MARGOT) [Phase 2]

View source ↗

Summary

Phase 2 trial update (MARGOT) compares MARGetuximab versus trastuzumab in HER2-positive breast cancer; results have been posted and the study is currently not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Margetuximab (margetuximab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Stage II Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-22